GB Sciences, Inc.GB Sciences, Inc.GB Sciences, Inc.

GB Sciences, Inc.

No trades
See on Supercharts
Market capitalization
‪40.71 K‬USD
−0.004100USD
‪−1.36 M‬USD
0.00USD
‪399.19 M‬
Beta (1Y)
−257.30
Employees (FY)
2
Change (1Y)
−1 −33.33%
Revenue / Employee (1Y)
0.00USD
Net income / Employee (1Y)
‪−680.84 K‬USD

About GB Sciences, Inc.


CEO
Andrea Small-Howard
Headquarters
Las Vegas
Founded
2001
FIGI
BBG000CY1L67
GB Sciences, Inc. is a biopharmaceutical research and development company, which engages in creating patented, disease-targeted formulations of cannabis, and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. The company was founded on April 4, 2001, and is headquartered in Las Vegas, NV.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of GBLX is 0.000100 USD — it hasn't changed in the past 24 hours. Watch GB Sciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange GB Sciences, Inc. stocks are traded under the ticker GBLX.
GBLX stock hasn't changed in a week, the month change is a ‪9.90 K‬% rise, over the last year GB Sciences, Inc. has showed a −98.18% decrease.
GBLX reached its all-time high on Jun 2, 2014 with the price of 3.490000 USD, and its all-time low was 0.000001 USD and was reached on Oct 22, 2024. View more price dynamics on GBLX chart.
See other stocks reaching their highest and lowest prices.
GBLX stock is 0.00% volatile and has beta coefficient of −257.30. Track GB Sciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is GB Sciences, Inc. there?
Today GB Sciences, Inc. has the market capitalization of ‪40.71 K‬, it has decreased by −66.67% over the last week.
Yes, you can track GB Sciences, Inc. financials in yearly and quarterly reports right on TradingView.
GBLX net income for the last quarter is ‪−467.05 K‬ USD, while the quarter before that showed ‪−187.28 K‬ USD of net income which accounts for −149.39% change. Track more GB Sciences, Inc. financial stats to get the full picture.
No, GBLX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 28, 2024, the company has 2.00 employees. See our rating of the largest employees — is GB Sciences, Inc. on this list?
Like other stocks, GBLX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GB Sciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GB Sciences, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GB Sciences, Inc. stock shows the sell signal. See more of GB Sciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.